← Leaderboards
Ronald C Eldridge
Emory University
$313,000
Attributed
$313,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $156.5K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$313,000 · 2
By mechanism
R03$313,000 · 2
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Thomas R Ziegler$10,822,263
- Judith L. Fridovich-Keil$9,505,935
- Louis J Elsas$3,518,058
- Vamsidhar Velcheti$2,348,633
- Shawn Hochman$7,971,412
Others in their field
Other Rising Stars on “Treatment Response”
- Angee Greer · Ppd Development Lp$82,531,927
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Suma Babu · Massachusetts General Hospital$11,004,714
- Sabrina Paganoni · Massachusetts General Hospital$11,004,714
- Alanna Maguire · Mayo Clinic Rochester$9,942,431
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
Research focus
Treatment ResponseHead And Neck CancerMetabolicSitePlasmaMetabolismFutureLinkMultiple OmicsQuality Of LifePrognosisBiological MarkersAmino AcidsMetabolomicsCohortFailureGrantClinical ResearchClinical TrialsChemotherapy And/Or RadiationClinically RelevantCoenzyme AAmino Acid MetabolismBile Acids
Grant awards (3)
Integrative Multi-Omics of Metabolomics and Epigenetics to Explore thePathophysiology of Cachexia and Survival in Head and Neck SquamousCell Carcinoma$156,500
R03 · FY2025 · CA · contact PI
Validating a prognostic plasma metabolomic biomarker to improve precision medicine in head and neck cancer patients$78,250
R03 · FY2024 · TR · contact PI
Validating a prognostic plasma metabolomic biomarker to improve precision medicine in head and neck cancer patients$78,250
R03 · FY2023 · TR · contact PI